Giasay test

Our goal is to help urologists more accurately determine the risk of prostate cancer from blood, even before a prostate biopsy. The Giasay® PROSTATE test is unique in that it assesses a parameter specific to prostate carcinoma, providing the highest accuracy of prostate cancer risk assessment of available blood tests.

Currently, company Glycanostics is entering the next strategic phase, which is based on collecting robust clinical evidence to include Giasay® Prostate test to standard diagnostic procedures and obtain reimbursement from public health insurance. All resources will be dedicated to further clinical research. We will continuously inform you about the progress and results through health authorities and articles.